Clinical Trial: Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704372) titled 'Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer' on July 03.

Brief Summary: To evaluate the efficacy and safety of superoxide dismutase skin spray for the reducing the acute radiation dermatitis in patients with head and neck malignancies undergoing radiotherapy.

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Radiation-induced Dermatitis

Intervention: DRUG: A topical superoxide dismutase skin spray

Patients are instructed to apply a topical superoxide dismutase-containing spray evenly to the entire radiotherapy-treated skin area, approximately 3 sprays ...